Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Biomarker Analysis in Metastatic Colorectal Cancer Treated With Cetuximab
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02029326
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients
- First Posted Date
- 2014-01-03
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 43
- Registration Number
- NCT02026583
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
Phase 2
Completed
- Conditions
- HER2-positive Gastric Cancer Patients With Liver Metastasis
- Interventions
- First Posted Date
- 2013-12-19
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT02015169
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Korea, Republic of
Perioperative Changes of Heart Rate Variability Related to Anxiety and Depressiveness in Patients Undergoing General Anesthesia
Completed
- Conditions
- SDSGeneral AnesthesiaHeart Rate VariabilitySTAIAnxiety
- First Posted Date
- 2013-12-13
- Last Posted Date
- 2014-11-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT02011074
- Locations
- 🇰🇷
Kim Myunghee, Gangnamgu, Seoul, Korea, Republic of
Naftopidil 75mg for Improving Clearance of Urinary Stones
- First Posted Date
- 2013-12-13
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 130
- Registration Number
- NCT02011737
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Extent of ILM Removal and Its Impact on Outcomes of MH Surgery
Not Applicable
Completed
- Conditions
- Macular Holes
- Interventions
- Procedure: large-extent peelingProcedure: small-extent peeling
- First Posted Date
- 2013-12-12
- Last Posted Date
- 2016-01-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 65
- Registration Number
- NCT02010138
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)
Phase 2
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Biological: MG4101
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT02008929
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Vasopressors for Cerebral Oxygenation
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2013-12-11
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT02009007
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke
Phase 4
Completed
- Conditions
- Cerebrolysin
- Interventions
- Drug: porcine brain peptide (Cerebrolysin)Drug: Placebo
- First Posted Date
- 2013-11-27
- Last Posted Date
- 2016-05-11
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 71
- Registration Number
- NCT01996761
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 98
- Registration Number
- NCT01991119
- Locations
- 🇰🇷
Cardiac and Vascular Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath